Literature DB >> 12888583

Bactericidal activity of levofloxacin against Mycoplasma pneumoniae.

Lynn B Duffy, Donna M Crabb, Xue Bing, Ken B Waites.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12888583     DOI: 10.1093/jac/dkg365

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumonia.

Authors:  Monica Fonseca-Aten; Christine M Salvatore; Asunción Mejías; Ana M Ríos; Susana Chávez-Bueno; Kathy Katz; Ana M Gómez; George H McCracken; R Doug Hardy
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 2.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

3.  Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.

Authors:  Ken B Waites; Donna M Crabb; Lynn B Duffy
Journal:  Antimicrob Agents Chemother       Date:  2008-07-28       Impact factor: 5.191

Review 4.  Levofloxacin : a review of its use as a high-dose, short-course treatment for bacterial infection.

Authors:  Vanessa R Anderson; Caroline M Perry
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy.

Authors:  Ayman M Noreddin; Walid F Elkhatib; Kenji M Cunnion; George G Zhanel
Journal:  Drug Healthc Patient Saf       Date:  2011-10-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.